In this issue:
RA treatment and mental health outcomes
2018 EULAR guideline on physical activity in iA and OA
Use Bactrim® prophylaxis in rituximab-treated patients?
Adalimumab vs DMARDs for venous thrombosis in Behçet’s syndrome
Exploring bDMARD-refractory disease in RA
TCZ vs TNFi ± csDMARDs in RA after the use of ≥1 bDMARD
Improving life expectancy of patients with scleroderma
Overdiagnosis and overtreatment in rheumatology
Can RA be transmitted through blood transfusion?
Outcomes of treat-to-target strategies in JIA
Please login below to download this issue (PDF)